Demonstration that fbiC Is Required by Mycobacterium bovis BCG for Coenzyme F(420) and FO Biosynthesis

Using the nitroimidazopyran-based antituberculosis drug PA-824 as a selective agent, transposon-generated Mycobacterium bovis strain BCG (M. bovis) mutants that could not make coenzyme F(420) were identified. Four independent mutants that could not make F(420) or the biosynthesis intermediate FO wer...

Täydet tiedot

Bibliografiset tiedot

Julkaisussa:	J Bacteriol
Päätekijät:	Choi, Kwang-Pil, Kendrick, Nathan, Daniels, Lacy
Aineistotyyppi:	Artigo
Kieli:	Inglês
Julkaistu:	American Society for Microbiology (ASM) 2002
Aiheet:	Physiology and Metabolism
Linkit:	https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC134996/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/11948155/ https://ncbi.nlm.nih.govhttps://doi.org/10.1128/JB.184.9.2420-2428.2002
Tagit:	Lisää tagi Ei tageja, Lisää ensimmäinen tagi!